Quality Analysis Evaluation and Research of Berberine Hydrochloride Tablets

Expand
  • Deyang Food and Drug Safety Inspection and Testing Center; Key Laboratory of Chemical Drug Quality Research of Sichuan
         Provincial Drug Administration,Sichuan Deyang 618000, China

Received date: 2025-06-25

  Revised date: 2025-08-01

  Accepted date: 2025-11-27

  Online published: 2025-12-15

Abstract

Objective: Based on provincial drug sampling inspections, this study evaluates and analyzes the quality of berberine hydrochloride tablets to clarify their current quality status, providing reference and suggestions for improving their quality standards and consistency evaluation. Methods: A total of 117 batches of berberine hydrochloride tablets were tested according to statutory standards, along with exploratory research. Results: The standard compliance rate of the tested tablets was 100%, with all indicators meeting current quality standards, indicating good safety and stability. Exploratory studies on dissolution, content determination, and elemental impurities revealed no abnormalities but identified areas for potential improvement. Conclusion: This study provides important reference for the consistency evaluation of berberine hydrochloride tablets, with subsequent recommendations to enhance quality standard refinement and regulatory oversight.

Cite this article

LONG Yingying, LIU Li, QIU Dongliang, ZHAO yuting, ZHANG Yueqian . Quality Analysis Evaluation and Research of Berberine Hydrochloride Tablets[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025 , 42(5) : 361 -361-365 . DOI: magtech-2025-06-25-00001

References

 [1] 齐飞,王国胜. 小檗红碱药理作用及其结构修饰研究进展 [J]. 药学研究, 2021, 40 (5): 324-328.
     [2] 张晨阳,张琳,杨卫利. 小檗碱及其体内代谢产物对高糖诱导大鼠H9c2心肌细胞损伤的保护作用 [J]. 药物评价研究, 2024, 47(1): 68-78.
     [3] 江苏省药品监督管理局. 江苏省2023年第12期药品质量通告[EB/OL]. (2023-12-15) [2024-08-01]. http://da. jiangsu. gov. cn/art/2023/12/15/art_15901_11104811. html.
     [4] 黑龙江省药品监督管理局. 黑龙江省2021年药品抽检不合格信息通报[EB/OL]. (2021-12-30) [2024-08-01]. http://mpa. hlj. gov. cn/art/2021/12/30/art_12294_10494585. html.
     [5] 北京市药品监督管理局. 北京市2012年第二季度药品抽验不合格汇总表[EB/OL]. (2012-07-25) [2024-08-01]. http://yjj. beijing. gov. cn/art/2012/7/25/art_5310_60470. html.
     [6] 何琳. 22批盐酸小檗碱片质量分析[J]. 中国药事,2018, 32(4): 512-515.
     [7] 许弘裕,黄传利,滕希峰,等. 盐酸小檗碱-胆盐复合物滴丸促进小檗碱口服吸收的体内外评价 [J]. 中国医药工业杂志, 2022, 53 (8): 1155-1161.
     [8] 国家药典委员会. 中华人民共和国药典(二部)[S]. 北京:中国医药科技出版社,2020.
     [9] 国家药典委员会. 中华人民共和国药典(2020年版第一增补本)[S]. 北京:中国医药科技出版社,2021.
     [10] 曹俊涵,施颖,张亿,等. 90批盐酸小檗碱片溶出度的测定和评价 [J]. 中国药物评价, 2018, 35 (2): 91-93.
     [11] 来灿林,侯梦妮,楼明波,等. HPLC-Q-TOF-MS/MS分析盐酸小檗碱的杂质谱 [J]. 中国现代应用药学, 2022, 39 (4): 512-523.
     [12] 周捷,杜宝萍,何欣,等. ICP-OES法测定康艾注射液原料药中重金属元素的含量 [J]. 海峡药学, 2019, 31 (11): 72-75.
     [13] 王宏亮. 金属参与的化学合成原料药元素杂质来源浅析 [J]. 药物评价研究, 2023, 46 (12): 2689-2698.
     [14] 吴娟娟,朱斌,史娟,等. 药用植物种植与生产地重金属污染分析与评价 [J]. 西北农林科技大学学报(自然科学版), 2022, 50(2): 103-114.
     [15] 吴金伟,但小梅,胡正林,等. 盐酸小檗碱原料药及其片剂杂质鉴定及分析方法建立 [J]. 中国药品标准, 2021, 22 (6): 520-526.
     [16] 原国家食品药品监督管理总局.国家食品药品监督管理总局关于发布普通口服固体制剂溶出度试验技术指导原则和化学药物(原料药和制剂)稳定性研究技术指导原则的通告(2015年第3号)[EB/OL]. (2015-02-05) [2024-08-01]. https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20150205120001100.html.
Outlines

/

[an error occurred while processing this directive]